However, serum AAT-A3F concentrations were significantly higher in the NASH group (7.63 ± 4.04 μM) than in the NAFL group (14.40 ± 14.08 μM; P < 0.001; Fig. 1b). Here, SERPINA1 is linked to metabolic dysfunction-associated steatohepatitis.